<?xml version="1.0" encoding="UTF-8"?>
<p>In development of a sequence-based predictor for predicting the biological activity, the feature extraction process is one of the most crucial aspects where peptide sequences are represented in a way that can afford a comprehensive and proper descriptor of the features reflecting their biological activities. Given a peptide sequence (
 <inline-formula>
  <math id="mm12">
   <mrow>
    <mstyle mathvariant="bold" mathsize="normal">
     <mi>P</mi>
    </mstyle>
   </mrow>
  </math>
 </inline-formula>), it can be represented as:
 <disp-formula id="FD5-ijms-20-05743">
  <label>(5)</label>
  <math id="mm13">
   <mrow>
    <mrow>
     <mstyle mathvariant="bold" mathsize="normal">
      <mi>P</mi>
     </mstyle>
     <mo>=</mo>
     <msub>
      <mi mathvariant="normal">p</mi>
      <mn>1</mn>
     </msub>
     <msub>
      <mi mathvariant="normal">p</mi>
      <mn>2</mn>
     </msub>
     <msub>
      <mi mathvariant="normal">p</mi>
      <mn>3</mn>
     </msub>
     <mo>â€¦</mo>
     <msub>
      <mi mathvariant="normal">p</mi>
      <mrow>
       <mn>1</mn>
       <mi mathvariant="normal">N</mi>
      </mrow>
     </msub>
    </mrow>
   </mrow>
  </math>
 </disp-formula> where 
 <inline-formula>
  <math id="mm14">
   <mrow>
    <mrow>
     <msub>
      <mi>p</mi>
      <mi>i</mi>
     </msub>
    </mrow>
   </mrow>
  </math>
 </inline-formula> and N denote the 
 <italic>i</italic>th residue in the peptide 
 <inline-formula>
  <math id="mm15">
   <mrow>
    <mstyle mathvariant="bold" mathsize="normal">
     <mi>P</mi>
    </mstyle>
   </mrow>
  </math>
 </inline-formula> and the peptide length, respectively. To develop the sequence-based predictor based on machine learning models, five different compositions and properties (i.e., AAC, DPC, PseAAC, Am-PseAAC, and GDC) that cover various aspects of sequence information were used. These five features have been successfully used to predict many peptides and proteins, such as human leukocyte antigen gene [
 <xref rid="B86-ijms-20-05743" ref-type="bibr">86</xref>,
 <xref rid="B87-ijms-20-05743" ref-type="bibr">87</xref>]; protein crystallization [
 <xref rid="B50-ijms-20-05743" ref-type="bibr">50</xref>,
 <xref rid="B88-ijms-20-05743" ref-type="bibr">88</xref>], the oligomeric states of fluorescent proteins [
 <xref rid="B89-ijms-20-05743" ref-type="bibr">89</xref>], the bioactivity of host defense peptides [
 <xref rid="B48-ijms-20-05743" ref-type="bibr">48</xref>], human leukocyte antigen gene [
 <xref rid="B86-ijms-20-05743" ref-type="bibr">86</xref>,
 <xref rid="B87-ijms-20-05743" ref-type="bibr">87</xref>], antifreeze proteins [
 <xref rid="B49-ijms-20-05743" ref-type="bibr">49</xref>], hemolytic activity of peptides [
 <xref rid="B46-ijms-20-05743" ref-type="bibr">46</xref>], antihypertensive activity of peptides [
 <xref rid="B47-ijms-20-05743" ref-type="bibr">47</xref>], and anti-angiogenic activity of peptides [
 <xref rid="B74-ijms-20-05743" ref-type="bibr">74</xref>].
</p>
